209 related articles for article (PubMed ID: 21781014)
1. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
Walker AD; Adachi JD
Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
[TBL] [Abstract][Full Text] [Related]
2. Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.
Perkins AC; Blackshaw PE; Hay PD; Lawes SC; Atherton CT; Dansereau RJ; Wagner LK; Schnell DJ; Spiller RC
Clin Ther; 2008 May; 30(5):834-44. PubMed ID: 18555931
[TBL] [Abstract][Full Text] [Related]
3. In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.
Dansereau RJ; Crail DJ; Perkins AC
Curr Med Res Opin; 2008 Apr; 24(4):1137-45. PubMed ID: 18334082
[TBL] [Abstract][Full Text] [Related]
4. In vitro disintegration studies of weekly generic alendronate sodium tablets (70 mg) available in the US.
Dansereau RJ; Crail DJ; Perkins AC
Curr Med Res Opin; 2009 Feb; 25(2):449-52. PubMed ID: 19192989
[TBL] [Abstract][Full Text] [Related]
5. Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.
Perkins AC; Frier M; Blackshaw PE; Spiller RC; Fairbairn KJ; Dansereau RJ; Kinghorn T; San P; Hosking D
Int J Pharm; 2006 Mar; 311(1-2):20-5. PubMed ID: 16431045
[TBL] [Abstract][Full Text] [Related]
6. Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes.
Dansereau RJ; Crail DJ
Ann Pharmacother; 2005 Jan; 39(1):63-7. PubMed ID: 15590875
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
Lee HL; Kan CD; Yang YJ
Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
[TBL] [Abstract][Full Text] [Related]
8. "Insight" into drug quality: comparison of simvastatin tablets from the US and Canada obtained via the Internet.
Veronin MA; Lee E; Lewis EN
Ann Pharmacother; 2007 Jul; 41(7):1111-5. PubMed ID: 17595307
[TBL] [Abstract][Full Text] [Related]
9. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
Ngo SN; Barnes T
Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
[TBL] [Abstract][Full Text] [Related]
10. Relative bio-availability of sultamicillin in healthy volunteers following administration of two tablet formulations.
Wildfeuer A; Zimmermann T; Eibel G; Lach P; Yeates R; Pfaff G
J Int Med Res; 1992; 20 Suppl 1():4A-11A. PubMed ID: 1451928
[TBL] [Abstract][Full Text] [Related]
11. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.
Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly J; Fischer MA; Kesselheim AS; Gagne JJ
BMJ; 2018 Apr; 361():k1180. PubMed ID: 29615391
[TBL] [Abstract][Full Text] [Related]
12. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
[TBL] [Abstract][Full Text] [Related]
14. Disintegration/dissolution profiles of copies of Fosamax (alendronate).
Epstein S; Cryer B; Ragi S; Zanchetta JR; Walliser J; Chow J; Johnson MA; Leyes AE
Curr Med Res Opin; 2003; 19(8):781-9. PubMed ID: 14687450
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
16. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
[TBL] [Abstract][Full Text] [Related]
17. Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
Tsai YS; Lan SK; Ou JH; Tzai TS
Clin Ther; 2007 Apr; 29(4):670-82. PubMed ID: 17617290
[TBL] [Abstract][Full Text] [Related]
18. Monthly risedronate (Actonel) for postmenopausal osteoporosis.
Med Lett Drugs Ther; 2008 Sep; 50(1294):69-70. PubMed ID: 18772843
[No Abstract] [Full Text] [Related]
19. Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers.
Blandizzi C; Viscomi GC; Marzo A; Scarpignato C
Pharmacol Res; 2014 Jul; 85():39-44. PubMed ID: 24836868
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.
Shakweh M; Bravo-Osuna I; Ponchel G
Eur J Pharm Sci; 2007 Aug; 31(5):262-70. PubMed ID: 17576054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
